Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer
Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer
Active, not recruiting · NCT03917082 · Registry updated 2023-06-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer | Breast Cancer Female; Hormone Receptor Positive Tumor | Active, not recruiting | Phase 2 | 2023-06-15 | NCT03917082 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| British Columbia Cancer Agency | 58 |
| Canadian Cancer Society (CCS) | 26 |
| NanoString Technologies, Inc. | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| BC Cancer | Vancouver | Canada | 6 |